Results 91 to 100 of about 54,799 (219)

Extracellular Vesicle cystatin c is associated with unstable angina in troponin negative patients with acute chest pain.

open access: yesPLoS ONE, 2020
BackgroundDespite the use of high-sensitive cardiac troponin there remains a group of high-sensitive cardiac troponin negative patients with unstable angina with a non-neglectable risk for future adverse cardiovascular events, emphasising the need for ...
Mirthe Dekker   +10 more
doaj   +1 more source

Reduction of recurrent ischemia with abciximab during continuous ECG-ischemia monitoring in patients with unstable angina refractory to standard treatment (CAPTURE) [PDF]

open access: yes, 1998
BACKGROUND: In the CAPTURE (c7E3 Fab Anti Platelet Therapy in Unstable REfractory angina) trial, 1265 patients with refractory unstable angina were treated with abciximab or placebo, in addition to standard treatment from 16 to 24 hours
Klootwijk, A.P.J. (Peter)   +4 more
core   +2 more sources

Albumin, urea‐to‐albumin ratio, or the albumin‐to‐creatinine ratio to predict outcomes in heart failure with mildly reduced ejection fraction

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
Among 2061 hospitalized HFmrEF patients, low albumin, albumin‐to‐creatinine ratios (ACR), and elevated urea‐to‐albumin ratios (UAR) independently predicted long‐term all‐cause mortality, but not HF‐related rehospitalization. The UAR and ACR did not provide a clinically significant predictive advantage over albumin levels alone. Abstract Background This
Alexander Schmitt   +11 more
wiley   +1 more source

Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. [PDF]

open access: yes, 1999
BACKGROUND: In patients with refractory unstable angina, the platelet glycoprotein IIb/IIIa-receptor antibody abciximab reduces the incidence of cardiac events before and during coronary angioplasty.
Adgey, J. (Jennifer)   +9 more
core   +2 more sources

Cost‐Utility Analysis of Left Bundle Branch Area Versus Biventricular Pacing for Cardiac Resynchronization Therapy: A Multicenter, Prospective, Quasi‐Experimental Study

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
Cost‐utility of LBBAP CRT versus BVP CRT. ABSTRACT Introduction Cardiac resynchronization therapy (CRT) is a well‐established treatment for patients with heart failure (HF). Recently, left bundle branch area pacing (LBBAP) has emerged as a more physiological alternative to biventricular pacing (BVP) for CRT.
José M. Sánchez‐Moreno   +8 more
wiley   +1 more source

EXERCISE TESTS IN UNSTABLE ANGINA SUSPECTS

open access: yesТерапевтический архив, 2012
The review is devoted to exercise tests (ET) potential in patients with different forms of coronary heart disease (CHD) exacerbation and suspected unstable angina.
M N Alekhin, N V Eremina, N F Radova
doaj  

THE INFLUENCE OF CELL AND PLASMA HEMOSTASIS AND BIOMARKER LEVELS ON CLINICAL OUTCOMES IN PATIENTS WITH UNSTABLE ANGINA AND RESISTANCE TO ANTIPLATELET AGENTS

open access: yesЕвразийский Кардиологический Журнал, 2016
SUMMARY Objective: to assess the impact of cell plasma hemostasis disorders and the level of biomarkers on clinical outcomes and to develop laboratory diagnostic criteria forecast recurrent coronary events in patients with unstable angina.
L. G. Gelis   +5 more
doaj   +1 more source

Serotonin reuptake inhibitors and cardiovascular disease [PDF]

open access: yes, 2005
Selective serotonin re-uptake inhibiting drugs (SSRIs) are widely used for endogenous depression. In addition to depleting the nerve terminals of serotonin they also lower blood platelet serotonin levels.
Belcher, P.R.   +2 more
core   +1 more source

Development and Implementation of a Medical Cannabis Clinic Within a Geriatrics Primary Care Clinic: Preliminary Data

open access: yesJournal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Cannabis use is rising among adults, yet few users receive structured medical supervision. Older users face unique risks necessitating specialized oversight. Given their longitudinal relationships and detailed understanding of patients' health and goals, primary care providers are well‐positioned to guide decisions and education ...
Ryan Weaver   +3 more
wiley   +1 more source

Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets [PDF]

open access: yes, 2003
Although tissue factor (TF), the principial initiator of physiological coagulation and pathological thrombosis, has recently been proposed to be present in human blood, the functional significance and location of the intravascular TF is unknown.
Alex, Meike   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy